Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 3/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | CCR2 | P41597 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 3/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19034641 | 1.00 | PRCP (0.51) | PRCPTLR2DPP7CCR2CNR1 | |
| SCHEMBL21105823 | 0.96 | PRCP (0.56) | PRCPTLR2DPP7CCR2CNR1 | |
| SCHEMBL16586012 | 0.82 | PRCP (0.41) | PRCPTLR2DPP7SLC6A3SLC6A2 | |
| SCHEMBL16586013 | 0.82 | PRCP (0.41) | PRCPTLR2DPP7SLC6A3SLC6A2 | |
| SCHEMBL26539681 | 0.80 | TLR2 (0.47) | PRCPTLR2DPP7NAAA | |
| SCHEMBL24219795 | 0.79 | TLR2 (0.45) | PRCPTLR2DPP7 | |
| SCHEMBL25438036 | 0.79 | TLR2 (0.42) | PRCPTLR2DPP7 | |
| SCHEMBL25438029 | 0.79 | TLR2 (0.42) | PRCPTLR2DPP7 | |
| SCHEMBL30284509 | 0.79 | TLR2 (0.42) | PRCPTLR2DPP7 | |
| SCHEMBL16829892 | 0.79 | TLR2 (0.48) | PRCPTLR2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382979-B2 | Biodegradable lipids for the delivery of active agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20220175929-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | BANK OF AMERICA, N.A. | 2022-06-09 | — | — | US | disclosed |
| US-20220175930-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | BANK OF AMERICA, N.A. | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175929-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | LIPA, APOB, CETP | PRCP 973/4885TLR2 1173/4885DPP7 836/4885 |
| US-11382979-B2 | Biodegradable lipids for the delivery of active agents | LIPA, APOB, CETP | PRCP 973/4885TLR2 1173/4885DPP7 836/4885 |
| US-20220175930-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | LIPA, APOB, CETP | PRCP 973/4885TLR2 1173/4885DPP7 836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.